Latest filing published 04 Sept 2024 for Calliditas Therapeutics AB, €183k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Henrik Stenqvist: trading record in brief
This profile gathers the share dealings of Henrik Stenqvist in Calliditas Therapeutics AB. Over a trading history stretching from 27 May 2022 to 2 September 2024, the count stands at 2 filings.
On the open market, the record shows 1 purchase worth €42k and 1 sale worth €183k. Taken together, the sales exceed the purchases by €141k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2024: no purchases and 1 sale on the market.
The newest entry dates from 4 September 2024: an open-market sale of €183k, in Calliditas Therapeutics AB. The latest purchase dates back some time: it was published 1,623 days ago, on 30 May 2022. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Henrik Stenqvist
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ SEK 208.0081.3% of flowAktieISIN SE0010441584FI:csv-84da0bcb2c6d1ba5b590
- 5,000 shares@ SEK 89.00100.0% of flowAktieISIN SE0010441584FI:csv-06f642177acb56c78d8eCanonical exit: 25 Aug 2022 (T+90)
2 of 2 declarations